VIVOZON

Your Happiness and well-being is our future

Science is the answer to disease and the key to our future

Challenge your thoughts to change the world

Vivozon develops new drugs through progressive thinking and solid scientific foundations

The Global Experts for Innovative Drug Discovery & Developments

Experts in new drug development are working together to ensure health, well-being, and happiness

Novel drug candidates for pain and central nervous system diseases Global PIPELINE more details: Opiranserin (VVZ-149) injection is a first-in-class non-narcotic analgesic under development by Vivozon. Vivozon is expanding its target combination of second-generation analgesic drug candidates and striving to expand its pipeline across the central nervous system disease field. more details

Core competencies for success Chemistry, Biology, Clinical. more details: Vivozon develops new chemical drugs that act on multi-targets to create synergistic efficacy. By applying efficacy-based screening from the early stage of discovery, we derive candidate substances with high potential for successful phase 2 clinical trials and continue with global clinical development. more details

Vivozon is at the forefront of the road to the future of humanity